These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 2871856)
1. The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension. Davey MJ Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):5S-8S. PubMed ID: 2871856 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension. Davey MJ Am J Med; 1989 Aug; 87(2A):36S-44S. PubMed ID: 2569823 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of alpha blockade for blood pressure control. Davey M Am J Cardiol; 1987 May; 59(14):18G-28G. PubMed ID: 2884849 [TBL] [Abstract][Full Text] [Related]
4. Review of the use of alpha-adrenoceptor antagonists in hypertension. Stokes GS; Marwood JF Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746 [TBL] [Abstract][Full Text] [Related]
6. Thiazide diuretics and selective alpha blockers: comparison of use in antihypertensive therapy, including possible differences in coronary heart disease risk reduction. Grimm RH Am J Med; 1987 Jan; 82(1A):26-30. PubMed ID: 2879460 [TBL] [Abstract][Full Text] [Related]
7. Drug of first choice in mild and moderate essential hypertension--clinical, hemodynamic and economic aspects. Lund-Johansen P Acta Med Scand Suppl; 1979; 626():69-72. PubMed ID: 34984 [No Abstract] [Full Text] [Related]
8. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
9. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Cubeddu LX Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387 [TBL] [Abstract][Full Text] [Related]
14. Combined alpha- and beta-receptor inhibition in the treatment of hypertension. Prichard BN Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891 [TBL] [Abstract][Full Text] [Related]
15. Influence of a new multifactorial antihypertensive on blood pressure and metabolic profile in essential hypertension associated with non-insulin-dependent diabetes mellitus. Fariello R; Boni E; Corda L; Zaninelli A; Noseda A; Spinazzi A Eur Heart J; 1992 Jun; 13 Suppl A():65-9. PubMed ID: 1356779 [No Abstract] [Full Text] [Related]
16. [Established blood pressure drug wins out in a comparative study. In hypertension, a diuretic first!]. Wepner U MMW Fortschr Med; 2003 Jan; 145(1-2):10-2. PubMed ID: 12638431 [No Abstract] [Full Text] [Related]
17. The pharmacology of prazosin, an alpha 1-adrenoceptor antagonist and the basis for its use in the treatment of essential hypertension. Davey MJ Clin Exp Hypertens A; 1982; 4(1-2):47-59. PubMed ID: 6122521 [TBL] [Abstract][Full Text] [Related]
18. An overview of the pharmacodynamic properties and therapeutic potential of combined alpha- and beta-adrenoceptor antagonists. van Zwieten PA Drugs; 1993 Apr; 45(4):509-17. PubMed ID: 7684671 [TBL] [Abstract][Full Text] [Related]
19. Side effects of antihypertensive drugs. Chrysant SG; Frohlich ED Am Fam Physician; 1974 Jan; 9(1):94-101. PubMed ID: 4149117 [No Abstract] [Full Text] [Related]
20. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension. Titmarsh S; Monk JP Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]